Financials

  • Market Capitalization 28.75 M
  • Employee 40
  • Founded 2015
  • CEO N/A
  • Website www.nextcure.com
  • Headquarter Delaware, United States
  • FIGI BBG00BTH5153
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.72
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4351
ATNM
Actinium Pharmaceuticals, Inc. Common Stock
1.00 USD-5.66%-10.71%-23.66%-3.85%31.44 M USD
4365
CVM
Cel-Sci Corporation Common Stock
1.74 USD-6.95%-37.18%+14.47%-66.21%30.60 M USD
4381
RNAZ
TransCode Therapeutics, Inc. - Common Stock
1.68 USD+3.07%-5.62%+1.82%-82.33%28.44 M USD
4388
IGC
IGC Pharma, Inc. Common Stock
0.27 USD-3.57%-3.57%-3.57%+5.39%27.91 M USD

Notizie